Gilead Analysts Spar Over Leaked Chinese Data Claiming Drug Flop

(Bloomberg) -- Gilead Sciences Inc. analysts offered a broad range of views on the inadvertently leaked abstract that indicated the company’s remdesivir failed to provide a benefit in a placebo-con...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.